




Cardiopulmonary Support and Physiology Raivio et al
4
CSPctivation of protein C and hemodynamic recovery after
oronary artery bypass surgery
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4 The Journal of Thoracic and Cardiovbjectives: Activated protein C is a physiologic anticoagulant that is activated by
hrombin and upregulated during coronary artery bypass grafting. We studied the
alance between thrombin generation and activated protein C levels during coronary
rtery bypass grafting and hypothesized that protein C activation during reperfusion
s associated with hemodynamic recovery or postoperative myocardial damage.
ethods: One hundred patients undergoing elective on-pump coronary artery by-
ass grafting were prospectively studied. Activated protein C, protein C, prothrom-
in fragment F12 (a marker of thrombin generation), and D-dimer (a marker of
brinolysis) levels were measured preoperatively and at 7 time points during
ardiopulmonary bypass and reperfusion and postoperatively. Hemodynamic pa-
ameters were measured serially. Cardiac biomarkers (mass of the Mb fraction of
reatine kinase and troponin T) were measured postoperatively.
esults: Reperfusion induced a significant increase in thrombin generation. Acti-
ated protein C levels peaked after heparin neutralization, when they increased more
han 3-fold. Activated protein C levels correlated with F12 and D-dimer levels
uring cardiopulmonary bypass and reperfusion. Even though this correlation
eaked during early reperfusion (r  0.55, P  .001), the ratio of activated protein
to F12 decreased during surgical intervention and early reperfusion by 70%
rom the preoperative level, indicating a marked delay in protein C activation in
elation to thrombin generation. Patients in the highest quintile of activated protein
levels during this period had a higher postoperative cardiac index (mean, 3.1 vs
.5 L · min1 · m2; P .05) and lower systemic vascular resistance (mean, 2137
s 2429 dyne · s · cm5 · m2; P  .05). Conversely, levels of preoperative
ctivated protein C and activated protein C measured after heparin neutralization
ere associated with unfavorable hemodynamic recovery postoperatively. Acti-
ated protein C or protein C levels were not associated with increased postoperative
ardiac biomarkers.
onclusions: Reperfusion caused significant thrombin generation that was followed
y activation of protein C. The balance of activated protein C with thrombin is
ssociated dynamically with postoperative hemodynamic recovery.
ctivated protein C (APC) is a physiologic anticoagulant that also possesses
anti-inflammatory and antiapoptotic properties.1,2 Protein C is activated by
thrombomodulin-bound thrombin. Initial generation of thrombin activates
rotein C, which further regulates thrombin formation. Initial thrombin generation
an therefore have a net antithrombotic effect. Propagated thrombin levels, on the
ther hand, are procoagulant, antifibrinolytic, and proinflammatory, despite the
ctivation of anticoagulant pathways.3 The dynamic balance between thrombin
eneration and protein C activation is of major importance in many clinical
ituations.
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PAfter experimental work that showed that APC pre-
ented mortality in a baboon model of bacteremia,4 APC
as emerged as a therapeutic option in human subjects. In
dult patients with sepsis, recombinant human APC re-
uced mortality and the incidence of organ failure.5,6
xperimental studies have shown evidence for beneficial
ffects of APC in various models of ischemia-reperfu-
ion.7 However, the complicated endothelial process of
rotein C activation, which results in on-demand nega-
ive feedback in response to thrombin generation, might
e disturbed by simultaneous activation of inflammation,
s in sepsis8 or severe pancreatitis.9
Cardiopulmonary bypass (CPB) and coronary artery
ypass grafting (CABG) cause significant activation of
oth coagulation and inflammation. During CPB, high
evels of both thrombin and APC are generated, and
eperfusion after CABG further causes a rapid and dis-
inct increase in both thrombin and APC levels.10,11 Pro-
ein C activation after CABG had an inverse correlation
ith neutrophil sequestration in the human myocardium
nd with L-selectin expression of circulating neutrophils,
mplicating APC as a possible regulator of myocardial
schemia-reperfusion injury.12 In a previous study we
howed that thrombin generation during reperfusion after
ABG is associated with postoperative myocardial dam-
ge and increased pulmonary vascular resistance.10 The
ame patient population was prospectively studied in this
tudy. Based on our finding that thrombin is associated
ith myocardial damage and a previous smaller study in
hich APC was associated with favorable hemodynamic
ecovery after CABG,11 our aim in this study was to
nvestigate the associations of protein C activation with
ostoperative hemodynamic recovery and myocardial
Abbreviations and Acronyms
AMI  acute myocardial infarction
ANOVA  analysis of variance
APC  activated protein C
CABG  coronary artery bypass grafting
CI  cardiac index
CK-Mbmmass of the Mb fraction of
creatine kinase
CPB  cardiopulmonary bypass
ICU  intensive care unit
PVRI  pulmonary vascular resistance index
SD  standard deviation
SVI  stroke volume index
SVRI  systemic vascular resistance index
TnT  troponin Tamage. i
The Journal of Thoracethods
tudy Setting and Patients
his was a prospective, single-center study of 100 consecutive
atients who were scheduled for primary, elective, on-pump
ABG. Exclusion criteria were as follows: use of warfarin, un-
ractionated or low-molecular-weight heparin, or aspirin less than
days before surgical intervention; renal failure; abnormal preop-
rative international normalized ratio; anemia; and thrombocyto-
enia. Institutional ethical committee approval and written in-
ormed consent from each patient were obtained. Anesthesia, CPB,
ransfusions, hemodynamic management, fluid therapy, and post-
perative medication followed a prospective clinical protocol, as
reviously described.10 The demographic and operative data have
een previously reported.10 Operative risk was evaluated accord-
ng to the EuroSCORE,13 which takes into account several patient-
elated, cardiac, and operation-related preoperative risk factors,
ncluding age; sex; the presence of pulmonary, neurologic, and
enal comorbidity; the presence of extracardiac arterial disease,
revious cardiac surgery, active endocarditis, unstable angina, left
entricular dysfunction, recent myocardial infarction, and pulmo-
ary hypertension; urgency; and the type of operation performed.
PB and Surgical Intervention
etails have been reported previously.10 During CPB nonpulsatile
ump flow, noncoated circuits and a membrane oxygenator (Tril-
ium Affinity; Medtronic, Minneapolis, Minn) were used in con-
unction with moderate systemic hypothermia. Pump flow was
aintained at 2.4 L · min1 · m2. Five thousand international
nits of unfractionated heparin was added to the priming solution,
nd an initial intravenous dose of 400 IU/kg heparin was admin-
stered. Heparinization was monitored with kaolin-activated clot-
ing time measurements every 20 minutes. Activated clotting time
as maintained at greater than 600 seconds by means of additional
oses of 5000 IU of heparin. During CPB, blood suctioned from
he operative field was returned to the systemic circulation through
filtered cardiotomy reservoir throughout the operation until pro-
amine administration. After CPB, the content of the extracorpo-
eal circuit was collected into nonanticoagulated blood bags and
eturned to the patient. Heparinization was neutralized with 1 mg
f protamine sulfate per 100 IU of heparin.
After median sternotomy, the left internal thoracic artery, right
nternal thoracic artery, saphenous vein, or radial artery grafts were
arvested. The ascending aorta and the right atrial appendage were
annulated, and CPB was initiated. Intermittent antegrade cold
10°C-12°C) blood cardioplegia was used for myocardial pro-
ection. The aorta was crossclamped during suturing of all anas-
omoses. The left internal thoracic artery was anastomosed to the
eft anterior descending coronary artery in all cases except one.
our patients also received a right internal thoracic artery graft.
dditional aortocoronary anastomoses were performed by using
aphenous vein or radial artery grafts. Intraoperative volume-flow
easurements of all grafts were performed with a transit-time
owmeter (Medi-Stim Butterfly Flowmeter; Medi-Stim AS, Oslo,
orway) to ascertain immediate graft patency.
emodynamic Measurements
radial artery cannula and a pulmonary artery catheter werenserted, and heart rate, arterial pressure, central venous pressure,
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CSPulmonary artery pressure, and pulmonary capillary wedge pres-
ure were measured. Cardiac output measurements were per-
ormed with thermodilution. Mean arterial pressure, mean pulmo-
ary artery pressure, stroke volume, stroke volume index (SVI),
ardiac index (CI), systemic vascular resistance index (SVRI), and
ulmonary vascular resistance index (PVRI) were calculated with
tandard formulas at 5 time points: preoperatively (coinciding with
ime point A for blood sampling, see below), after termination of
PB (time point E), on arrival in the intensive care unit (ICU), 6
ours after protamine (time point F), and on the first postoperative
ay (time point G).
emodynamic Management
hen the postoperative CI value was less than 2.0 L · min1 ·
2
, pulmonary capillary wedge pressure was first adjusted to 12
o 15 mm Hg by optimizing preload with an infusion of Ringer’s
cetate, 6% hydroxyethyl starch, or 4% human albumin. If the CI
alue remained less than 2.0 L · min1 · m2, epinephrine
0.02-0.2 g · kg1 · min1) was infused. If the CI value still
emained less than 2.0 L · min1 · m2, a milrinone infusion
0.5 g · kg1 · min1) was added. When the mean arterial
ressure was less than 70 mm Hg, preload was first optimized (see
bove), and when necessary, norepinephrine (0.01-0.1 g · kg1
· min1) was infused.
Preoperatively, after the induction of anesthesia (corresponding
o time point A, see “Hemodynamic measurements” above and
Blood samples” below), 28% of the patients required a norepi-
ephrine infusion, and none of the patients received either epi-
ephrine or milrinone. During CPB, before the release of the aortic
lamp (time points B and C), 77% of the patients received nor-
pinephrine, 5% received epinephrine, and none of the patients
eceived milrinone. After the release of the aortic clamp, during
arly reperfusion and 30 minutes after heparin neutralization (time
oints D and E), 90% of the patients received norepinephrine, 84%
eceived epinephrine, and 7% received milrinone. Postoperatively,
n arrival in the ICU, 75% of the patients received norepinephrine,
1% received epinephrine, and 7% received milrinone. Six hours
fter heparin neutralization (time point F), 87% of the patients
eceived norepinephrine, 71% received epinephrine, and 6% re-
eived milrinone, and on the morning of the first postoperative day
time point G), 37% of the patients received norepinephrine, 27%
eceived epinephrine, and 4% received milrinone.
Use of epinephrine during CPB (time points B and C) and
uring early reperfusion (time points D and E) was associated with
igher postoperative PVRI and SVRI, respectively (repeated-
easures analysis of variance [ANOVA]: P  .003 and P  .014,
espectively). Use of norepinephrine preoperatively (time point A)
nd during CPB (time points B and C) was associated with higher
ostoperative SVI (P  .042 and P  .046, respectively). Use of
ilrinone during early reperfusion was associated with lower
ostoperative SVRI (P  .036). Otherwise, use of vasoactive
edications was not associated with subsequent hemodynamic
arameters.
lood Samples
lood samples were collected at 8 time points (points A-H):
reoperatively (point A), at 15 minutes of CPB (point B), imme-
iately before the release of the aortic clamp (point C), 15 minutes a
6 The Journal of Thoracic and Cardiovascular Surgery ● Januafter the release of the aortic clamp (point D), 30 minutes (point E)
nd 6 hours (point F) after protamine administration, and on the
rst (point G) and fifth (point H) postoperative days. Samples A
hrough G were collected through a radial artery catheter, and
ample H was collected either through an atraumatic venipuncture
r through a radial artery catheter. Samples for measurement of
12 and D-dimer levels were collected into vacuum test tubes
ith 3.8% sodium citrate. For measurement of APC levels, a
itrate benzamidine anticoagulant mixture was used according to
he method of Gruber and Griffin.14 The first 5 mL of each sample
ere discarded. The samples were cooled on ice and centrifuged
1500g for 10 minutes) at 4°C. Plasma was separated and stored
t 80°C.
aboratory Analyses
PC and protein C were analyzed with an enzyme capture assay,
s previously described,14 and values are given as mean percent-
ges of normal pooled human plasma. Prothrombin fragment
12 was analyzed with an enzyme-linked immunoassay (Enzyg-
ost F12micro; Dade Behring, Marburg, Germany), as previ-
usly described.10 Soluble fibrin monomer complexes and D-
imer levels were measured with immunoturbidimetric assays
STA-Liatest FM; Diagnostika Stago, Asnieres, France; and Tina-
uant D-Dimer; Roche Diagnostics GmbH, Mannheim, Germany).
evels of the cardiac biomarkers mass of the Mb fraction of
reatine kinase (CK-Mbm) and troponin T (TnT) were determined
ith electrochemiluminescence immunoassays (Elecsys Ck-Mb-
TAT and Elecsys TroponinTSTAT, Roche Diagnostics GmbH).
PC, protein C, F12, and D-dimer levels were measured from all
atients at all time points (see above); soluble fibrin monomer
omplexes were measured from patients 1 to 20 at time points A
o F; and CK-Mbm and TnT levels were measured from all
atients at time point G (18 hours postoperatively).
tatistical Analysis
he data were analyzed with the SPSS for Windows 11.5.1 soft-
are (SPSS, Inc, Chicago, Ill) and the NCSS 2000 software
NCSS, Kaysville, Utah). For clarity, all data are presented as the
ean and standard deviation (SD) or as the mean and standard
rror of the mean. Analysis of normality of the distribution of
ontinuous variables was performed with the Kolmogorov-
mirnov test. For univariate analysis of the association between
ariables, the Pearson and Spearman rank correlation coefficients
ere calculated, as appropriate. Differences between the repeated
easurements were analyzed with repeated-measures ANOVA,
nd post-hoc comparisons were made with the Fisher least-signif-
cant-difference multiple-comparison test. Variables with skewed
istribution were natural logarithmically transformed before these
nalyses. For multivariable logistic regression analysis, a forward
tepwise method was used. Known preoperative clinical risk fac-
ors of CABG (EuroSCORE and the presence of diabetes) and a set
f intraoperative variables (aortic crossclamp time, number of
istal anastomoses, blood loss during the operation, and cumula-
ive heparin dose) were tested with F12 levels at various time
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Pesults
ifferent Kinetics of APC and Thrombin and Fibrin
ormation
PC levels decreased slightly after the initiation of CPB,
nd during ischemia, there was only a slight increase in the
evel of APC. Maximal upregulation of APC levels was
bserved after heparin neutralization (time point E), when
he APC level increased more than 3-fold (Figure 1, A). The
eak APC level ranged from 178% to 1267% (mean, 546%;
D, 84%).
Thrombin generation (F12) increased steadily during
schemia, and reperfusion further increased the rate of
hrombin generation (Figure 1, A). Soluble fibrin monomer
omplexes were measured from patients 1 to 20 to investi-
ate whether the increase in thrombin generation was asso-
iated with synchronous fibrin formation (Figure 1, B).
ibrin monomer complex levels increased in parallel with
12 levels, and the rate of fibrin formation exceeded the
ate of thrombin generation. Postoperatively (time point F),
he ratio of the level of fibrin monomer complexes to F12
as more than 2.5-fold compared with the preoperative
atio (Figure 1, C). Protein C activation was clearly delayed
n relation to both F12 and fibrin formation (Figure 1,
-C). APC/protein C and APC/F12 ratios were calculated
o further characterize the activation status of protein C.
ecause of little variation in protein C levels (mean, 72%-
5%), changes in APC/protein C ratios were similar to
hanges in absolute APC levels. Overall, throughout the
tudy, the APC/F12 ratio was less than preoperatively
repeated-measures ANOVA: P  .001), indicating a dom-
nance of thrombin generation over protein C activation
Figure 1, C).
Three phases of the balance between APC and F12
evels could be identified (Figure 1, C). First, after the
nitiation of CPB and during ischemia (time points A-C),
PC/F12 ratio decreased by more than 60%, apparently
ecause of increasing thrombin generation without a re-
ponse by APC. There was therefore a marked delay in the
ncrease in APC levels in relation to F12 levels. During
arly reperfusion (time point D), the APC level already
learly increased, yet the APC/F12 ratio further decreased
ecause of a burst in thrombin generation.
Second, after heparin neutralization (time point E), both
12 and APC levels peaked, with the APC response being
ore pronounced, and there was a shift in the APC/F12
alance. Thereafter, APC levels decreased more rapidly
han F12 levels.
Finally, on the first postoperative day (time point G),
oth APC and F12 levels were low, and from postopera-
ive day 1 to 5 (time points G-H), APC levels decreased,
hereas F12 levels increased, again causing the APC/
12 balance to be shifted back toward thrombin
ominance. d
The Journal of Thoraceterminants of Protein C Activation
n univariate analyses APC levels correlated with F12
evels (Table 1) and D-dimer levels (correlation coefficients
rom r  0.33 to r  0.49, P  .001) during CPB and
eperfusion. The strength of this correlation increased dur-
ng CPB and myocardial ischemia and peaked during early
eperfusion (time point D). Peak APC and peak APC/pro-
ein C levels (time point E) correlated weakly with aortic
rossclamp time (r  0.31, P  .001 and r  0.32, P 
016, respectively) and CPB time (r  0.35, P  .001 and
 0.36, P  .001, respectively).
Multiple patient- and operation-related clinical variables
nd F12 levels (see “Statistical analysis”) were tested in
ultivariable logistic regression analysis for associations
ith protein C activation. F12 levels were associated with
PC levels at all time points, as expected (data not shown).
PC and Hemodynamic Recovery
PC levels immediately before the release of the aortic clamp
ad weak positive correlations with CI values after CPB (time
oint E) and on arrival in the ICU (r  0.21, P  .037 and r
0.22, P  .03, respectively) and negative correlations with
VRI values measured during the same time points (r 
0.20, P .04 and r0.26, P .012, respectively). APC
evels during early reperfusion (time point D) had a weak
egative correlation with postoperative SVRI values (r 
0.25, P .013). Because the kinetics of protein C activation
nd thrombin formation differed from each other, we sepa-
ately analyzed whether the highest or lowest deciles or quin-
iles of either absolute levels of APC, APC/protein C ratio, or,
lternatively, APC/F12 balance were associated with post-
perative hemodynamic measurements.
High preoperative APC levels were associated with an
nfavorable postoperative hemodynamic profile. Patients
ith preoperative APC/protein C ratios (time point A) in the
ighest decile had lower CI values postoperatively than
thers (repeated-measures ANOVA: P  .026, Figure 2).
onversely, patients with preoperative APC levels in the
owest decile or quintile had lower PVRI values postoper-
tively (time points F and G; mean PVRI, 345 vs 225 dyne
· s · cm5 · m2 and 246 vs 173 dyne · s · cm5 · m2,
espectively; P  .005 and P  .02, respectively).
At the end of cardiac ischemia, immediately before the
elease of the aortic clamp (time point C) and during early
eperfusion 15 minutes after the release of the aortic clamp
time point D), protein C activation was associated with an
pposite and favorable hemodynamic response. Patients
ith APC levels in the highest quintile before the release of
he aortic clamp had higher CI values postoperatively than
thers (P  .03, Figure 3). Those with APC/protein C ratios
n the highest quintile during early reperfusion had lower
VRI values postoperatively (mean SVRI, 2137 vs 2429
yne · s · cm5 · m2; P  .045). Consistently, those
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CSPith APC/F12 ratios in the lowest decile or quintile
efore the release of the aortic clamp (P  .01 and P 
007, respectively) and during early reperfusion (P  .001
nd P  .04, respectively) had higher postoperative PVRI
alues on arrival in the ICU (data not shown).
After heparin neutralization with protamine (time point
), APC levels were associated again with an inferior he-
odynamic profile. Those with APC levels in the highest
ecile after heparin neutralization had lower SVI values
ostoperatively (P  .026, Figure 4). Conversely, patients
ho had APC levels in the lowest decile measured during
he same time point (time point E) had a trend toward higher
ostoperative SVI and CI values, which did not reach sta-
istical significance. Those with APC/protein C ratios in the
ighest decile or quintile after heparin neutralization had
igher postoperative PVRI values than others (mean PVRI
f highest quintile, 472 vs 343 dyne · s · cm5 · m2; P
.04).
igure 1. Changes in levels of activated protein C (APC; panels A
nd B), prothrombin fragment F12 (panel A),10 soluble fibrin
onomer complexes (panel B), and ratios of APC to F12 (APC/
12; panel C) and soluble fibrin monomer complexes to F12
panel C). The mean preoperative ratios were arbitrarily adjusted
o 1.0 to better illustrate their differential kinetics. Time points
easured are preoperatively (A), at 15 minutes of CPB (B), imme-
iately before the release of the aortic clamp (C), 15 minutes after
he release of the aortic clamp (D), 30 minutes (E) and 6 hours (F)
fter protamine administration, and on the first (G) and fifth (H)
ostoperative days. The time scale reflects actual time between
ime points A through F. Time points G and H are not in scale.
ABLE 1. Correlation between prothrombin fragment F12
nd activated protein C levels
Activated protein C









orrelation between prothrombin fragment F12 and activated protein C at
arious time points: preoperatively (A), at 15 minutes of CPB (B), immedi-
tely before the release of the aortic clamp (C), 15 minutes after the
elease of the aortic clamp (D), 30 minutes (E) and 6 hours (F) after
rotamine administration, and on the first (G) and fifth (H) postoperative
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PPatients who required norepinephrine and epinephrine on
he morning of the first postoperative day had higher peak
PC levels (time point E) than others (repeated-measures
NOVA: P  .007 and P  .001, respectively). Otherwise,
se of vasoactive medications was not associated with APC
evels.
PC and Myocardial Damage
he mean postoperative CK-Mbm level was 42 g/L (SD,
2 g/L), and the mean TnT level was 0.75 g/L (SD, 0.69
g/L). APC or protein C levels did not correlate with
ostoperative cardiac biomarker levels (CK-Mbm or TnT,
ata not shown). The patients were stratified into groups
ccording to the extent of cardiac biomarker release. Pa-
ients with evidence of postoperative myocardial damage
efined as either a CK-Mbm level of 100 g/L or greater
nd a CK-Mbm level of 69 g/L or greater (90th and
80th percentile, respectively) or a TnT level of 1.61 g/L
igure 2. Cardiac index of patients with preoperative activated
rotein C to protein C ratio (APC/PC) in the highest decile versus
thers. Time points measured are preoperatively (A), after termi-
ation of cardiopulmonary bypass (E), postoperatively on arrival
n the intensive care unit (ICU), 6 hours after protamine adminis-
ration (F), and on the first postoperative day (G). The time scale
eflects actual time between time points A through F. Time point
is not in scale. *Repeated-measures analysis of variance: P <
05 between groups. Values are presented as means  standard
rror of the mean.r greater and a TnT level of 1.24 g/L or greater (90th w
The Journal of Thoracnd 80th percentile, respectively) did not have APC or
rotein C levels different from those of other patients
repeated-measures ANOVA: data not shown). Also, pa-
ients with new Q-waves postoperatively (n  7), who were
ll in the highest quintile of CK-Mbm and TnT levels, did
ot have APC levels different from those of other patients
repeated-measures ANOVA: data not shown).
iscussion
uring CABG, the activation of protein C was associated
losely with thrombin generation, and the correlation be-
ween APC and F12 levels was strongest during early
eperfusion. However, thrombin and fibrin formation both
receded and dominated over APC. When an early response
f APC to thrombin generation was observed (ie, at the end
f ischemia and during early reperfusion), the postoperative
emodynamic profile was favorable. Conversely, high pre-
perative APC levels and high peak APC levels, which
oincided with peak thrombin generation, were associated
igure 3. Cardiac index of patients with activated protein C (APC)
evels in the highest quintile before the release of the aortic
lamp (time point C) versus others. Time points measured are
reoperatively (A), after termination of cardiopulmonary bypass
E), postoperatively on arrival in the intensive care unit (ICU), 6
ours after protamine administration (F), and on the first postop-
rative day (G). The time scale reflects actual time between time
oints A through F. Time point G is not in scale. *Repeated-
easures analysis of variance: P < .05 between groups. Values
re presented as means  standard error of the mean.ith unfavorable postoperative hemodynamic performance.
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CSPhe peak APC level observed in this study probably reflects
lose to the maximal physiologic APC level because it is
ell comparable with maximal APC levels observed in liver
nd renal transplantation, which represent clinical settings
ith strong reperfusion-induced activation of protein C.15,16
lso, the maximal APC levels observed in patients with
epsis8 or severe pancreatitis,9 2 conditions with systemic
nflammation and coagulopathy, were similar or less than
he current maximal APC levels. Despite the dynamic as-
ociation of APC levels with postoperative hemodynamic
ecovery, there was no association between protein C acti-
ation and evidence of postoperative myocardial damage.
Experimental evidence suggests that APC levels might
ave beneficial effects on ischemia-reperfusion–induced tis-
ue damage. APC has reduced ischemia-reperfusion–
nduced organ injury in the brain,17,18 spinal cord,19 kid-
ey,20 intestine,21 and myocardium.22 It could be expected
hat in a clinical situation after myocardial ischemia and
igure 4. Stroke volume index of patients with activated protein
(APC) levels in the highest decile after heparin neutralization
time point E) versus others. Time points measured are preoper-
tively (A), after termination of cardiopulmonary bypass (E), post-
peratively on arrival in the intensive care unit (ICU), 6 hours after
rotamine administration (F), and on the first postoperative day
G). The time scale reflects actual time between time points A
hrough F. Time point G is not in scale. *Repeated-measures
nalysis of variance: P < .05 between groups. Values are pre-
ented as means  standard error of the mean.eperfusion and myocardial stunning, activation of protein A
0 The Journal of Thoracic and Cardiovascular Surgery ● Januawould be associated with enhanced myocardial recovery.
n a previous smaller study protein C activation during early
eperfusion after CABG was associated with improved he-
odynamic recovery after CABG.11 This finding is now
onfirmed. However, the unfavorable associations between
reoperative and peak APC levels and postoperative hemo-
ynamics in the present study were unexpected. Even
hough the explanation remains beyond the scope of the
resent study, high APC levels before surgical intervention
ight indicate a secondary response to an underlying
hrombin challenge produced by a stressed and more patho-
ogic endothelium throughout the vasculature. If so, the
istorted thrombin-APC balance could logically be associ-
ted with unfavorable hemodynamic performance after sur-
ical intervention. We have previously shown that thrombin
eneration during reperfusion was associated with myocar-
ial damage and that thrombin generation after heparin
eutralization was associated with increased postoperative
ulmonary resistance.10 Therefore the observed association
etween peak protein C activation after heparin neutraliza-
ion and an unfavorable hemodynamic profile might be
ogical if we assume that the response by APC to the
hrombin challenge observed was maximal but insufficient
o reverse the possible negative effects of thrombin. Also,
ther mediators could be involved. Thrombin activates
hrombin-activatable fibrinolysis inhibitor, the role of which
s unknown during CPB. It is possible that during a burst
nd propagation of thrombin generation, activation of
hrombin-activatable fibrinolysis inhibitor could lead to re-
uced fibrinolysis in the microcirculation, which, in turn,
ould be associated with hemodynamic control indepen-
ently of protein C activation.
We did not find an association between APC levels and
ostoperative myocardial damage. A previous clinical study
hat examined the association of APC levels with the re-
ponsiveness to thrombolytic therapy for acute myocardial
nfarction (AMI) found an association with increased APC
evel and unsuccessful thrombolysis.23 Patients with ST-
egment elevation AMI had higher APC levels than control
ubjects, and patients with failed infarct-related coronary
rtery recanalization had higher APC levels than patients
ith successful thrombolysis after AMI. However, rather
han ST-segment elevation AMI, our patients had postop-
rative cardiac biomarker increase, the mechanism of which
s known to differ from that of cardiac biomarker increase in
MI not related to CABG.24
The present study has some limitations. It was designed
o be large enough to detect possible associations between
PC levels and postoperatively measured continuous vari-
bles (ie, hemodynamic measurements and the levels of
ardiac biomarkers) and could have been underpowered to
etect an association between APC levels and postoperative
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Pot allow direct conclusions to be made about the possible
echanisms of the associations detected.
We conclude that this is the first study of its size to
emonstrate an association between preoperative and intra-
perative APC levels and APC/thrombin balance and post-
perative sequelae after CABG. The study is novel in dem-
nstrating that protein C activation is delayed in relation to
hrombin generation and that protein C activation is asso-
iated dynamically with hemodynamic recovery after
ABG. Because thrombin generation during reperfusion
fter CABG has been previously implicated to be associated
ith myocardial damage and compromised hemodynamic
ecovery,10 the finding that APC levels are associated with
emodynamic recovery after CABG is logical. Overall, the
ata add to the evidence that suggests that hypercoagulation
fter CABG, especially during reperfusion, might be a clin-
cally important phenomenon.
The expert technical assistance of Anne Karhu in blood sam-
ling is greatly appreciated.
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